Literature DB >> 18480005

Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.

Cary J Buresh1, Bahram Robert Oliai, Rodney T Miller.   

Abstract

Merkel cell carcinoma (MCC) is a high-grade neuroendocrine carcinoma of skin characterized by cells with a "blastic" appearance, scant cytoplasm, and fine, evenly distributed chromatin. Terminal deoxynucleotidyl transferase (TdT) is a DNA polymerase present in thymic T cells, lymphoblastic lymphoma/leukemia, and some cases of acute myeloid leukemia. After observing TdT immunoreactivity in a case of MCC, we analyzed 26 tumors by immunohistochemical analysis to determine their spectrum of reactivity with TdT and identified TdT in 19 (73%) of 26 MCCs. Staining intensity was variable but was often moderate to strong and present in a significant percentage of cells. Because MCC has cytomorphologic features similar to those of lymphoblastic lymphoma and may manifest as metastatic disease, reactivity with TdT in MCC could represent a diagnostic pitfall in the differential diagnosis with lymphoblastic lymphoma, particularly because the latter may lack CD45 and/or CD20, yet both neoplasms may express PAX-5, a B-cell-associated marker.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480005     DOI: 10.1309/R494HQ9VRDJWDY30

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

Review 1.  [Merkel cell carcinoma: cutaneous manifestation of a highly malignant pre-/pro-B cell neoplasia? : Novel concept about the cellular origin of Merkel cell carcinoma].

Authors:  C M Sauer; E Chteinberg; D Rennspiess; A K Kurz; A Zur Hausen
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

Review 2.  Merkel Cell Carcinoma.

Authors:  Melissa Pulitzer
Journal:  Surg Pathol Clin       Date:  2017-03-14

3.  A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT.

Authors:  Gregory A Hosler; Teresa Davoli; Ilgen Mender; Brandon Litzner; Jaehyuk Choi; Payal Kapur; Jerry W Shay; Richard C Wang
Journal:  J Cutan Pathol       Date:  2014-12-11       Impact factor: 1.587

Review 4.  Update on Merkel Cell Carcinoma.

Authors:  Michael T Tetzlaff; Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-03-20

5.  Merkel cell carcinoma with partial B-cell blastic immunophenotype: a potential mimic of cutaneous richter transformation in a patient with chronic lymphocytic lymphoma.

Authors:  John A Papalas; Matthew S McKinney; Evan Kulbacki; Sandeep S Dave; Endi Wang
Journal:  Am J Dermatopathol       Date:  2014-02       Impact factor: 1.533

6.  Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression.

Authors:  Kishor Bhatia; James J Goedert; Rama Modali; Liliana Preiss; Leona W Ayers
Journal:  Int J Cancer       Date:  2010-05-01       Impact factor: 7.396

7.  Merkel cell carcinoma metastatic to the testis: report of a rare diagnosis and review of the literature.

Authors:  Davide Gigliano; João Lobo; Paula Lopes; Ivo Julião; Francisco Lobo; Rosa Azevedo; Rui Henrique; Ângelo Rodrigues
Journal:  Autops Case Rep       Date:  2020-12-08

Review 8.  Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update.

Authors:  Leigh A Compton; George F Murphy; Christine G Lian
Journal:  Dermatopathology (Basel)       Date:  2015-04-08

Review 9.  Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome.

Authors:  Mona M Ahmed; Camille H Cushman; James A DeCaprio
Journal:  Viruses       Date:  2021-12-30       Impact factor: 5.048

Review 10.  Merkel Cell Carcinoma: From Pathobiology to Clinical Management.

Authors:  Peerzada Umar Farooq Baba; Zubaida Rasool; Ishrat Younas Khan; Clay J Cockerell; Richard Wang; Martin Kassir; Henner Stege; Stephan Grabbe; Mohamad Goldust
Journal:  Biology (Basel)       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.